OM Outset Medical, Inc.: Market Capitalization to Book Value Ratio

Official company branding of outsetmedical.com (OM)

Outset Medical, Inc. (OM) is growing its business based on compact dialysis devices, covering both inpatient departments and the home treatment sector. The company scales profits through the sale of high-cost components, which reduces costs as the installed base of equipment expands. The current figure is 0.80. The price action shown below reflects the impact of the Tablo system implementation and the growth of recurring payments for consumables on the quotes.

OM Outset Medical Corp: Market Value to Book Value in the range 07/04/2022 - 10/27/2026
Signature product of Outset Medical Inc

The multiplier is calculated as the ratio of the total market value of all shares to the value of net assets, determining the size of the market premium over book capital. Analyzing this metric of the market's valuation of book capitalization provides insight into the extent to which investors are overvaluing the assets of Outset Medical, Inc. (OM), given the growth potential of its hybrid sales model for portable dialysis between clinics and private patients.

Main competitors

Market Capitalization to Book Value Ratio DexCom, Inc. DXCM|penumbrainc.com (PEN) - Market Value to Book Value|Market Capitalization to Book Value Ratio NOVT (Novanta)|Market-to-Book Ratio HAE|Inspire Sleep (INSP) - Market Value to Book Value Ratio|Market Value to Book Value Procept (PRCT)|Market Capitalization to Book Value Ratio CNMD (CONMED Corporation)|pulsebiosciences.com - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio InMode|PMI - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio SRDX|Market-to-Book Ratio Senseonics Holdings, Inc.|NPCE (NeuroPace, Inc.) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio Tactile Systems Technology Inc. (TCMD)|Market Cap to Net Assets Ratio SANUWAVE|Market Cap to Book Value Multiple smartvest.com (ELMD)|Market Capitalization to Book Value Ratio LNSR|Market Capitalization to Book Value AVITA Medical Inc RCEL|PROF: Market Capitalization to Book Value Ratio|Baird Medical Investment (BDMD) - Market Cap to Net Assets Ratio|Market Cap to Net Assets Ratio edap-tms.com EDAP|APYX (Apyx Medical Corporation) - Market Value to Book Value|Market Value to Book Value Ratio ICCM|Market Cap to Net Assets Ratio Pulmonx Corp.|TELA Bio, Inc. - Market Capitalization to Book Value Ratio|Market-to-Book Ratio cytosorbents.com (CTSO)|SRTS - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio Zynex Medical ZYXI|Market Capitalization to Book Value Ratio ECOR (electroCore Medical)|RBOT - Market Capitalization to Book Value|IINN (inspira-technologies.com) - Market Capitalization to Book Value Ratio|seastarmedical.com (ICU) - Market Cap to Net Assets Ratio|IRIX (IRIDEX Corp) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio INBS|Market Value to Book Value Ratio Beyond Air, Inc. (XAIR)|Market Value to Book Value Ratio Profusa, Inc PFSA|Market Cap to Net Assets Ratio STRATA Skin Sciences, Inc.|Market Value to Book Value GlucoTrack Inc. GCTK|NAOV (NanoVibronix, Inc.) - Market Capitalization to Book Value Ratio|VERO: Market-to-Book Ratio|Market Value to Book Value Ratio NUWE (CHF Solutions)|Market Value to Equity Ratio Aethlon Medical Corp|ASXC (Asensus Surgical Inc) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio avinger.com|BSGM (biosig.com) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value CUTR (Cutera Inc.)|Know Labs Corp (KNW) - Market Value to Book Value Ratio|Inari Medical Corp - Market Capitalization to Net Assets|NVRO: Market Value to Book Value Ratio|RSLS - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio SILK